Clinical and histological evolution after de novo donor-specific anti-human leukocyte antigen antibodies: a single centre retrospective study

BACKGROUND: Donor-specific anti-human leukocyte antigen (HLA) antibodies (DSA) can be preformed or de novo (dn). Strategies to manage preformed DSA are well described, but data on the management and outcomes of dnDSA are lacking. METHODS: We performed a retrospective analysis of data from a single c...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouatou, Yassine, Seyde, Olivia, Moll, Solange, Martin, Pierre-Yves, Villard, Jean, Ferrari-Lacraz, Sylvie, Hadaya, Karine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898072/
https://www.ncbi.nlm.nih.gov/pubmed/29649973
http://dx.doi.org/10.1186/s12882-018-0886-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898072/
https://www.ncbi.nlm.nih.gov/pubmed/29649973
http://dx.doi.org/10.1186/s12882-018-0886-5

Ejemplares similares